{"id":9004111222137708,"date":"2020-06-24T12:51:33","date_gmt":"2020-06-24T11:51:33","guid":{"rendered":"https:\/\/www.hgf.com\/?p=9004111222137708"},"modified":"2025-11-13T20:13:09","modified_gmt":"2025-11-13T20:13:09","slug":"considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils","status":"publish","type":"post","link":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/","title":{"rendered":"Consid\u00e9rations relatives \u00e0 la propri\u00e9t\u00e9 intellectuelle dans le d\u00e9veloppement des vaccins contre la COVID-19&nbsp;: tensions et outils"},"content":{"rendered":"<p class=\"p__large\">Le d\u00e9veloppement des vaccins contre la COVID-19 g\u00e9n\u00e9rera une propri\u00e9t\u00e9 intellectuelle pr\u00e9cieuse qui pourrait \u00eatre prot\u00e9g\u00e9e par des brevets.<\/p>\n<p>Cependant, \u00e9tant donn\u00e9 qu&#8217;une demande de brevet n&#8217;est publi\u00e9e qu&#8217;environ 18 mois apr\u00e8s sa date de d\u00e9p\u00f4t initiale, nous ne pouvons pas encore voir quels types d&#8217;inventions sont vis\u00e9s, qui d\u00e9pose des brevets et o\u00f9 les brevets sont d\u00e9pos\u00e9s pour prot\u00e9ger les inventions li\u00e9es \u00e0 la COVID-19. Compte tenu de la nature de la pand\u00e9mie qui affecte la majorit\u00e9 de la population mondiale, de sa propagation rapide et des complications graves qu&#8217;elle provoque, certains peuvent se demander si toute propri\u00e9t\u00e9 intellectuelle d\u00e9velopp\u00e9e dans ce domaine devrait \u00eatre soumise \u00e0 une protection par des parties priv\u00e9es d\u00e8s le d\u00e9part. <\/p>\n<p>La Partenaire d&#8217;HGF, Dr Leena Contarino, et l&#8217;Avocate Senior en Brevets, Ellie Purnell, examinent la tension per\u00e7ue entre la protection par brevet et le partage d&#8217;informations en p\u00e9riode de besoin de collaboration et de rapidit\u00e9, et sugg\u00e8rent que, comme le d\u00e9montre la campagne de vaccination contre Ebola, la protection par brevet, le partage d&#8217;informations et la collaboration ne sont pas n\u00e9cessairement des entreprises mutuellement exclusives.<\/p>\n<p>Elles proposent que, bien que certains syst\u00e8mes de licences simplifi\u00e9s qui pourraient \u00eatre des outils pour acc\u00e9l\u00e9rer le partage, tels que les initiatives de mutualisation des brevets inspir\u00e9es par l&#8217;industrie des t\u00e9l\u00e9communications et de l&#8217;\u00e9lectronique, rencontrent encore une r\u00e9sistance parmi certaines entreprises pharmaceutiques, le d\u00e9veloppement d&#8217;une meilleure plateforme de partage d&#8217;informations pour les technologies vaccinales pourrait servir \u00e0 acc\u00e9l\u00e9rer les collaborations en temps de crise. Vous pouvez en savoir plus sur les d\u00e9fis li\u00e9s aux licences COVID-19 <a href=\"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/defis-de-licence-lies-a-la-covid-19\/\">ici<\/a>. <\/p>\n<p class=\"p__medium\"><a href=\"https:\/\/www.hgf.com\/wp-content\/uploads\/2023\/01\/IP-considerations-in-COVID-19-vaccine-development.pdf\">Cliquez ici pour lire l&#8217;article complet<\/a> pr\u00e9par\u00e9 par la Partenaire d&#8217;HGF, Dr Leena Contarino, et l&#8217;Avocate Senior en Brevets <a href=\"https:\/\/www.hgf.com\/fr\/our-people\/eleanor-purnell\/\">Ellie Purnell<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le d\u00e9veloppement des vaccins contre la COVID-19 g\u00e9n\u00e9rera une propri\u00e9t\u00e9 intellectuelle pr\u00e9cieuse qui pourrait \u00eatre prot\u00e9g\u00e9e par des brevets. Cependant, \u00e9tant donn\u00e9 qu&#8217;une demande de brevet n&#8217;est publi\u00e9e qu&#8217;environ 18 &hellip;<\/p>\n","protected":false},"author":315,"featured_media":9004111222138423,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[536,517],"tags":[],"class_list":["post-9004111222137708","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-centre-de-connaissances","sector-produits-pharmaceutiques","service-brevets","sector_groups-sciences-de-la-vie"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Consid\u00e9rations relatives \u00e0 la propri\u00e9t\u00e9 intellectuelle dans le d\u00e9veloppement des vaccins contre la COVID-19&nbsp;: tensions et outils - HGF<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Consid\u00e9rations relatives \u00e0 la propri\u00e9t\u00e9 intellectuelle dans le d\u00e9veloppement des vaccins contre la COVID-19&nbsp;: tensions et outils\" \/>\n<meta property=\"og:description\" content=\"Le d\u00e9veloppement des vaccins contre la COVID-19 g\u00e9n\u00e9rera une propri\u00e9t\u00e9 intellectuelle pr\u00e9cieuse qui pourrait \u00eatre prot\u00e9g\u00e9e par des brevets. Cependant,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/\" \/>\n<meta property=\"og:site_name\" content=\"HGF\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-24T11:51:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-13T20:13:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hgf.com\/wp-content\/uploads\/2020\/03\/COVID-19-contractual-and-legal-considerations.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Akvil\u0117 Lukauskaite\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@behrooz@tall.agency\" \/>\n<meta name=\"twitter:site\" content=\"@hgf_ip\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Akvil\u0117 Lukauskaite\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\\\/\"},\"author\":{\"name\":\"Akvil\u0117 Lukauskaite\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#\\\/schema\\\/person\\\/e6343663c5ee3e1ccea20cd220f97f30\"},\"headline\":\"Consid\u00e9rations relatives \u00e0 la propri\u00e9t\u00e9 intellectuelle dans le d\u00e9veloppement des vaccins contre la COVID-19&nbsp;: tensions et outils\",\"datePublished\":\"2020-06-24T11:51:33+00:00\",\"dateModified\":\"2025-11-13T20:13:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\\\/\"},\"wordCount\":356,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.hgf.com\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/COVID-19-contractual-and-legal-considerations.jpg\",\"articleSection\":[\"Articles\",\"Centre de connaissances\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\\\/\",\"url\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\\\/\",\"name\":\"Consid\u00e9rations relatives \u00e0 la propri\u00e9t\u00e9 intellectuelle dans le d\u00e9veloppement des vaccins contre la COVID-19&nbsp;: tensions et outils - HGF\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.hgf.com\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/COVID-19-contractual-and-legal-considerations.jpg\",\"datePublished\":\"2020-06-24T11:51:33+00:00\",\"dateModified\":\"2025-11-13T20:13:09+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/centre-de-connaissances\\\/articles\\\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.hgf.com\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/COVID-19-contractual-and-legal-considerations.jpg\",\"contentUrl\":\"https:\\\/\\\/www.hgf.com\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/COVID-19-contractual-and-legal-considerations.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/\",\"name\":\"HGF\",\"description\":\"Intellectual Property Rights specialists\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#organization\",\"name\":\"HGF\",\"url\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hgf.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/hgf-logo-696x696-1.png\",\"contentUrl\":\"https:\\\/\\\/www.hgf.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/hgf-logo-696x696-1.png\",\"width\":696,\"height\":696,\"caption\":\"HGF\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hgf_ip\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hgf-limited-intellectual-property-specialists\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#\\\/schema\\\/person\\\/e6343663c5ee3e1ccea20cd220f97f30\",\"name\":\"Akvil\u0117 Lukauskaite\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d9cf1622c8c99b4c7573ba733a04f6352d3557803ca19afd3e4aafc94d9bc0b8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d9cf1622c8c99b4c7573ba733a04f6352d3557803ca19afd3e4aafc94d9bc0b8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d9cf1622c8c99b4c7573ba733a04f6352d3557803ca19afd3e4aafc94d9bc0b8?s=96&d=mm&r=g\",\"caption\":\"Akvil\u0117 Lukauskaite\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/behrooz@tall.agency\",\"Behrooz Saeed\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Consid\u00e9rations relatives \u00e0 la propri\u00e9t\u00e9 intellectuelle dans le d\u00e9veloppement des vaccins contre la COVID-19&nbsp;: tensions et outils - HGF","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/","og_locale":"fr_FR","og_type":"article","og_title":"Consid\u00e9rations relatives \u00e0 la propri\u00e9t\u00e9 intellectuelle dans le d\u00e9veloppement des vaccins contre la COVID-19&nbsp;: tensions et outils","og_description":"Le d\u00e9veloppement des vaccins contre la COVID-19 g\u00e9n\u00e9rera une propri\u00e9t\u00e9 intellectuelle pr\u00e9cieuse qui pourrait \u00eatre prot\u00e9g\u00e9e par des brevets. Cependant,","og_url":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/","og_site_name":"HGF","article_published_time":"2020-06-24T11:51:33+00:00","article_modified_time":"2025-11-13T20:13:09+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.hgf.com\/wp-content\/uploads\/2020\/03\/COVID-19-contractual-and-legal-considerations.jpg","type":"image\/jpeg"}],"author":"Akvil\u0117 Lukauskaite","twitter_card":"summary_large_image","twitter_creator":"@behrooz@tall.agency","twitter_site":"@hgf_ip","twitter_misc":{"\u00c9crit par":"Akvil\u0117 Lukauskaite","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/#article","isPartOf":{"@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/"},"author":{"name":"Akvil\u0117 Lukauskaite","@id":"https:\/\/www.hgf.com\/fr\/#\/schema\/person\/e6343663c5ee3e1ccea20cd220f97f30"},"headline":"Consid\u00e9rations relatives \u00e0 la propri\u00e9t\u00e9 intellectuelle dans le d\u00e9veloppement des vaccins contre la COVID-19&nbsp;: tensions et outils","datePublished":"2020-06-24T11:51:33+00:00","dateModified":"2025-11-13T20:13:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/"},"wordCount":356,"commentCount":0,"publisher":{"@id":"https:\/\/www.hgf.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/#primaryimage"},"thumbnailUrl":"https:\/\/www.hgf.com\/wp-content\/uploads\/2020\/03\/COVID-19-contractual-and-legal-considerations.jpg","articleSection":["Articles","Centre de connaissances"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/","url":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/","name":"Consid\u00e9rations relatives \u00e0 la propri\u00e9t\u00e9 intellectuelle dans le d\u00e9veloppement des vaccins contre la COVID-19&nbsp;: tensions et outils - HGF","isPartOf":{"@id":"https:\/\/www.hgf.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/#primaryimage"},"image":{"@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/#primaryimage"},"thumbnailUrl":"https:\/\/www.hgf.com\/wp-content\/uploads\/2020\/03\/COVID-19-contractual-and-legal-considerations.jpg","datePublished":"2020-06-24T11:51:33+00:00","dateModified":"2025-11-13T20:13:09+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.hgf.com\/fr\/centre-de-connaissances\/articles\/considerations-relatives-a-la-propriete-intellectuelle-dans-le-developpement-des-vaccins-contre-la-covid-19-tensions-et-outils\/#primaryimage","url":"https:\/\/www.hgf.com\/wp-content\/uploads\/2020\/03\/COVID-19-contractual-and-legal-considerations.jpg","contentUrl":"https:\/\/www.hgf.com\/wp-content\/uploads\/2020\/03\/COVID-19-contractual-and-legal-considerations.jpg","width":1920,"height":1080},{"@type":"WebSite","@id":"https:\/\/www.hgf.com\/fr\/#website","url":"https:\/\/www.hgf.com\/fr\/","name":"HGF","description":"Intellectual Property Rights specialists","publisher":{"@id":"https:\/\/www.hgf.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hgf.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.hgf.com\/fr\/#organization","name":"HGF","url":"https:\/\/www.hgf.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.hgf.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.hgf.com\/wp-content\/uploads\/2023\/04\/hgf-logo-696x696-1.png","contentUrl":"https:\/\/www.hgf.com\/wp-content\/uploads\/2023\/04\/hgf-logo-696x696-1.png","width":696,"height":696,"caption":"HGF"},"image":{"@id":"https:\/\/www.hgf.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hgf_ip","https:\/\/www.linkedin.com\/company\/hgf-limited-intellectual-property-specialists\/"]},{"@type":"Person","@id":"https:\/\/www.hgf.com\/fr\/#\/schema\/person\/e6343663c5ee3e1ccea20cd220f97f30","name":"Akvil\u0117 Lukauskaite","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/d9cf1622c8c99b4c7573ba733a04f6352d3557803ca19afd3e4aafc94d9bc0b8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d9cf1622c8c99b4c7573ba733a04f6352d3557803ca19afd3e4aafc94d9bc0b8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d9cf1622c8c99b4c7573ba733a04f6352d3557803ca19afd3e4aafc94d9bc0b8?s=96&d=mm&r=g","caption":"Akvil\u0117 Lukauskaite"},"sameAs":["https:\/\/x.com\/behrooz@tall.agency","Behrooz Saeed"]}]}},"_links":{"self":[{"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/posts\/9004111222137708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/users\/315"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/comments?post=9004111222137708"}],"version-history":[{"count":0,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/posts\/9004111222137708\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/media\/9004111222138423"}],"wp:attachment":[{"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/media?parent=9004111222137708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/categories?post=9004111222137708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/tags?post=9004111222137708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}